SAVING LIVES THROUGH EXCELLENCE IN
BIO-MANUFACTURING
VISION
To be a preferred partner for improving health and well-being of all, now and for generations to come.
MISSION
As a responsible and reliable member in Global healthcare community, we focus on:
The development and manufacturing of vaccines and biopharmaceuticals through cutting-edge state-of-art technologies. As well as the creation and completion of Biopharmaceutical industry ecosystems in ASEAN and beyond.
AN OPPORTUNITY IN THAILAND AND ASEAN
LIFE-CHANGING RESULTS THROUGH THAILAND’S HIGH BIODIVERSITY AND FIRM POSITION AS THE MEDICAL HUB OF ASEAN.
FACTS & FIGURES
Number of ASEAN population
622 million
ASEAN’s combined GDP of
$2.8 trillion
3rd fastest growing major
Indo-Pacific economy
WHY THAILAND?
8th most bio-diverse region in the world:
Plants, animals, and humans
2nd biggest pharmaceutical market
in ASEAN and 8th in Asia
World class medical hub
with a large pool of highly qualified doctors
High quality CRO at a reasonable price
due to numerous creditable doctors, investigators, and university hospitals
Abundant related trial subjects
such as the pre-clinical trial production and number of patient cases
Gateway to ASEAN
ASEAN Harmonization (harmonized requirement for document supports)
ONE-STOP-SERVICE CDMO IN THAILAND AND ASEAN
To be a preferred partner for improving health and well-being of all, now and for generations to come.
As a joint venture of Thai private sector, led by internationally experienced Bio Pharma engineers together with business veterans, and Korean leading biotech company called “Genexine with a cGMP compliant biotech CDMO facility, we provide a one-stop-service from biopharma process development to fill & finish.
Our expertise lies in our experience in plasmid DNA, recombinant proteins, and monoclonal antibodies, Biopharma Manufacturing Process Development and Technology Transfer while being independent with robust access to academia.
We possess advanced technology to increase yield as to greatly reduce cost and time with regulatory expertise including a strong track record of quality, compliance, and regulartory expertise.
HARMONIOUS COLLABORATION
Experienced in various inter-organization projects with both local and international organization.
Strong network with Academia and Life Science Government agencies in Thailand
GLOBAL NETWORK
Leverage global network from our partner company, a leading biotechnology company in South Korea and our management’s strong network in Life Science Industry in the EU
ASEAN SUPPORT
A hub for ASEAN/regional biopharmaceutical production
For the best pharmaceutical development mankind has to offer – not only in Thailand but also in neighboring countries
OUR SITE
KinGen Biotech provides CDMO services for the biopharmaceutical industry and R&D community through its operations at Thailand’s National Biopharmaceutical Facility (NBF), a state-of-the-art Pilot-scale GMP facility in Bangkok, Thailand.
KinGen Biotech provides CDMO services for the biopharmaceutical industry and R&D community through its operations at Thailand’s National Biopharmaceutical Facility (NBF), a state-of-the-art Pilot-scale GMP facility in Bangkok, Thailand.
OUR ALLIANCE
Genexine in involved in the research and development (R&D) of innovative immunotherapeutic drugs and next-generation antibody fusion proteins. The company is also actively involved in commercializing these products. In addition, Genexine is currently developing innovative therapeutic drugs to fulfill its mission of saving patient lives and improving their quality of life.
King Mongkut’s University of Technology Thonburi (KMUTT) was founded as a research university serving as both educational park and industrial park. KMUTT, as a leading university in technology, currently produces qualified graduates and skillful human resources with strong quality and morality ground. The university actively involves in research and development as well as provides quality academic services contributing to enhancement of economy and quality of life.
KMUTT Research and Innovation Strategy designated seven strategic research themes, anchored by the university’s core capabilities including Sustainable Energy and Environment, Sustainable Bioeconomy, Digital Transformation, Innovative Materials, Manufacturing & Construction, Sustainable Mobility, Smart Healthcare, and Creative and Learning Society.